Company / Debt per Share
Astria Therapeutics, Inc. Debt per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.15
FY2017
5-year range
-
FY2016-FY2017
Trend
+220.8%
vs FY2016
Sector context
#56 of 82
Health Care
What the data says
At $1.15, Astria Therapeutics, Inc.'s debt per share ranks #27 of 82 in the Health Care sector.
Based on SEC 10-K filings.
1.15 in FY2017.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#27 of 82 in Health CareTop 32% of 82This company $1.15 Sector average $151.59
▼
-99.2% below sector average
Key checks
Key Insights
- In FY2017, debt per share increased 220.8% year-over-year.
- Ranks #56 out of 82 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $1.15 | +220.8% |
| FY2016 | $0.36 | - |
| FY2015 | - | - |
As of FY2017 · SEC 10-K · Updated Feb 28, 2026